Novartis was created in 1996 from the merger of the Swiss based life sciences companies, Ciba-Geigy and Sandoz, both Swiss companies with long histories.

Since the merger in 1996, Novartis has transformed itself from a diverse group, including agribusiness, to a highly focused leading healthcare company.

Novartis UK is the UK affiliate of Swiss-based Novartis AG, one of the largest and most widely respected pharmaceutical companies in the world.

Novartis UK employs over 3,500 people on 9 sites. In the UK the Novartis sites are involved in manufacturing, packaging, customer service and marketing for products used in the UK and worldwide.

The Respiratory Research Centre at Horsham employs over 300 scientists in a £42 million purpose-built centre.

Horsham is the global research centre for gastro-intestinal research for Novartis.

Novartis Vaccines facility in Liverpool is the UK's only large-scale producer of influenza vaccines and the company is still investing heavily in new manufacturing facilities at the site.

Novartis has invested over £600 million in the Grimsby manufacturing site over the last 15 years.

Novartis made revenues of over $42 billion in 2008.

Daniel Vasella is the current Chairman of the board and CEO.

If you want to have further information, click Internship.

If you want to apply for an internship in Novartis, click Internship.